KUWAIT MEDICAL JOURNAL, vol.52, no.4, pp.426-430, 2020 (SCI-Expanded)
Objective: This study was performed to determine the polymorphism frequencies of the Angiotensin II type 1 receptor (AT1) A1166C, and to examine the role of this polymorphism in type-2 diabetes (T2DM) and diabetic nephropathy (DN) development.